A Delicate Balance: Maintaining Mutualism to Prevent Disease  by Van Tyne, Daria & Gilmore, Michael S.
Cell Host & Microbe
Previewsfor human Chagas disease, in which
the myocarditis is associated with persis-
tent infection. Nonetheless, the studies
validate the selection of target antigens
that are invariant, subdominant, and
exposed early in the infectious cycle, as
a general strategy to undermine the
immune evasive capacity of vector borne
parasites.
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The intestinal microbial ecosystem is complex, and few of the principles that contribute to homeostasis in
health are well understood. Pham et al. (2014) show that a network including the epithelial interleukin-22
receptor protects against infection with the opportunistic pathogen Enterococcus faecalis through promo-
tion of host-microbiota mutualism.The human gastrointestinal (GI) tract is
a rich and highly complex ecosystem,
where a wide variety of bacterial, fungal,
and viral inhabitants coexist with one
other and in symbiosis with their host.
This diverse microbial community aids
digestion, synthesizes vitamins, and pro-
tects the host against infection. But the
microbiota exists in a delicate balance
that is periodically disrupted, resulting in
a state of microbial dysbiosis. The factors
that precipitate microbial dysbiosis, and
how to prevent or reverse it, are not well
understood.
Recent studies point to the complex
interplay between diet, community com-
plexity, and host immunity in maintaining
GI tract microbial homeostasis (Turn-
baugh et al., 2009; Jernberg et al., 2007;
Deatherage Kaiser et al., 2013). Not sur-
prisingly, diet is an important factor in
determining GI community composition.
When host diet shifts, the compositionof the GI microbial ecosystem also
shifts (Turnbaugh et al., 2009). Over the
past 50 years, antibiotic treatment has
emerged as an important cause of micro-
bial dysbiosis; broad-spectrum antimi-
crobials fundamentally change the
composition of GI tract flora, and the
effects can persist for years (Jernberg
et al., 2007). Infection with a virulent path-
ogen such as Salmonella can also alter
community structure and result in dysbio-
sis (Deatherage Kaiser et al., 2013).
Finally, the host immune system plays a
key role inmaintaining amicrobial homeo-
stasis compatible with health. The im-
mune system is ‘‘trained’’ as healthy flora
are established during development and
becomes capable of distinguishing be-
tween beneficial and harmful GI tract
microbes. When working properly, the
immune system is able to promote the
occurrence of the former and suppress
the latter. But when this training goesawry, or when host immunity is disrupted,
the GI tract ecosystem can tilt toward
dysbiosis and disease (Figure 1).
What are the key interactions between
the host immune system and the GI tract
microbial community that contribute to
or prevent dysbiosis? In this issue, Pham
and colleagues explore the role of the
interleukin-22 receptor IL-22RA1 in main-
taining microbial homeostasis in the
mouse GI tract (Pham et al., 2014).
Because intestinal inflammation can
cause dysbiosis, the authors hypothe-
sized that IL-22RA1 contributes to
maintaining microbial homeostasis by
restricting the overgrowth of opportu-
nistic pathogens. In a series of experi-
ments in mice lacking IL-22RA1, the
authors demonstrate that during micro-
bial dysbiosis, the opportunistic pathogen
Enterococcus faecalis is able to expand in
relative abundance in the intestinal tract
and then translocate to the bloodstream6, October 8, 2014 ª2014 Elsevier Inc. 425
Figure 1. Driving Forces in the Balance between Gastrointestinal Tract Homeostasis and
Dysbiosis
On the left, healthy GI tract homeostasis is characterized by a large diversity of microbes, an intact mucin
layer, epithelial cells decorated with fucosylated glycans, and patrolling immune cells that produce anti-
bodies, cytokines such as IL-22, and other antimicrobial peptides, all of which help regulate the microbial
community. Disruptive forces such as changes in diet, infection with a virulent microbe, inflammation,
and/or antibiotic use can shift the community to a state of dysbiosis, shown on the right. In this state,
the microbial community is thrown off balance, and the host is prone to systemic infection with entero-
cocci. Administering probiotic bacteria, or simply probiotic metabolites such as 20-fucosyllactose, can
help restore microbial homeostasis.
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signaling through IL-22RA1 results in in-
duction of the fucosyltransferase Fut2,
which helps restore community diversity,
possibly through increased availability of
fucosylated oligosaccharides such as
20-fucosyllactose. Another recent study
found that fucosylation of intestinal
epithelial cells is regulated by Fut2 and
depends upon the interleukin-22 (IL-22)
cytokine (Goto et al., 2014). Collectively,
these findings lead to a model whereby
IL-22, IL-22RA1, and Fut2 help maintain
host-microbiota mutualism by promoting
the growth of probiotic anaerobic bacteria
belonging to the Ruminococcus and Bac-
teroides genera, which thrive on fucosy-
lated glycans (Figure 1). Promoting the
growth of these commensal anaerobes
would limit the overgrowth of E. faecalis,
thus maintaining microbial homeostasis.
The selective outgrowth of enterococci
following intestinal dysbiosis is emerging
as a common theme, regardless of
whether dysbiosis results from antibiotic
treatment, intestinal inflammation, or
infection. Administration of broad-spec-
trum antimicrobials decreases commu-
nity diversity and is associated with
intestinal dominance and systemic infec-
tion with enterococci (Ubeda et al.,
2010). Antibiotic treatment also eliminates
microbe-derived products, such as the426 Cell Host & Microbe 16, October 8, 2014flagella of Gram-negative organisms,
from the intestinal niche. Normally,
these microbe-derived products stimu-
late secretion of host defense molecules,
such as RegIIIg, into the mucosa. With
reduced antimicrobial RegIIIg expression,
enterococci are able to overgrow in the
intestine and ultimately invade the blood-
stream (Kinnebrew et al., 2010). Further-
more, a recent study of microbiota
changes following intestinal surgery
found that anastomotic injury, and pre-
sumably the resulting inflammation,
caused a 500-fold increase in the relative
abundance of enterococci in the intestinal
tissue-associated microbiota (Shogan
et al., 2014). Finally, infection of mice
with Salmonella enterica serovar Typhi-
murium has been found to induce GI tract
inflammation and microbial dysbiosis and
again lead to increased abundance of
enterococci (Deatherage Kaiser et al.,
2013). The commonality between these
studies is the elimination of probiotic
commensal microbes and the selective
expansion of enterococci to high density,
presumably because of the lack of
competition for nutrients and space.
The enterococci belong to an ancient
genus that we believe arose with the
development of the microbiota in com-
plex life forms and has evolved along
with the tree of life (Van Tyne and Gilmore,ª2014 Elsevier Inc.2014). Today, enterococci are found in a
wide range of hosts that spans the animal
kingdom, from insects to man. Two
Enterococcus species, E. faecalis and
E. faecium, have become well-adapted
hospital pathogens and are common
causes of antibiotic-resistant infection.
E. faecalis and to a lesser extent
E. faecium are also core members of the
healthy human GI tract microbiota, and
for this reason, when they overgrow and
infect ordinarily sterile sites, they are
referred to as opportunistic pathogens.
Enterococci can cause urinary tract infec-
tions, endocarditis, sepsis, and wound
infections; these infections are particu-
larly difficult to treat because of intrinsic
antibiotic resistance, stemming from the
inherent ruggedness of the bacteria and
additional resistances that have been
acquired on mobile genetic elements.
What unique features allow entero-
cocci to proliferate when microbial ho-
meostasis is disrupted? In addition to
intrinsic and acquired antibiotic resis-
tances, E. faecalis and E. faecium are
able to resist other antimicrobial factors,
such as bile, and are able to tolerate a
wide variety of stressors that would elim-
inate their competitors. Furthermore,
enterococci are able to persist in the envi-
ronment longer than other bacteria; if they
were similarly able to persist longer in the
perturbed GI tract, they would gain
access to a competitor-free niche, where
they could resume growth when the
opportunity arises. While these and other
factors likely contribute to the prolifera-
tion of enterococci during GI tract dysbio-
sis, many of the mechanistic details
underlying this phenomenon remain to
be discovered.
What can be done to reverse or prevent
microbial dysbiosis and thus prevent sub-
sequent enterococcal infections? Main-
taining a diverse GI tract microbial
community appears to be crucial, but
how can diversity be restored therapeuti-
cally? On an ecosystem level, transplan-
tation of normal microbial flora from a
healthy donor has been used successfully
to manage GI tract ecology and restore
population diversity in patients suffering
from chronic infection with Clostridium
difficile (Lo Vecchio and Cohen, 2014).
With specific reference to limiting entero-
coccal overgrowth, activation of the IL-22
receptor is a theoretical possibility but is
complicated by the fact that the receptor
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Previewsoccurs on a variety of cell types and is
connected to multiple signaling networks.
Restoring community diversity with obli-
gate anaerobes, such as Barnsiella, Bac-
teroides, or Ruminococcus, could also
be worthwhile. The findings of Pham and
colleagues, however, suggest a direct
and simpler approach: administration of
fucosylated oligosaccharides, such as
20-fucosyllactose, which may do much to
restore community complexity and pro-
mote homeostasis.
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In this issue of Cell Host & Microbe, Hammer et al. (2014) show that distinct, slow-growing bacteria have bet-
ter in vitro and in vivo growth and virulence when cocultured than in isolation. They provide evidence that the
observed inter- and intraspecies ‘‘complementation’’ involves the intercellular exchange of metabolites.Laboratory culture is a mainstay of medi-
cal bacteriology. The ability to grow a
pathogen in pure culture is the basis for
one of Koch’s postulates—the criteria
presented by Robert Koch in 1890 to
establish relationships between individual
pathogens and disease (Fredericks and
Relman, 1996). Since then, much of med-
ical microbiology, including the identifica-
tion of infecting bacteria, testing their
in vitro susceptibilities to antibiotics, and
probing myriad other behaviors, relies on
laboratory growth in pure, single-species
(i.e., ‘‘axenic’’) cultures. These methods
have been refined for well over a century,
resulting in a dizzying array of media
and techniques, and allowing for ever-
improved capacity for bacterial cultiva-
tion, identification, and discrimination.The usefulness of axenic cultures is
undeniable; these techniques have been
invaluable in diagnosing and choosing
treatments for innumerable infections.
These methods have also proven to be
incredibly powerful for investigating the
inner workings of specific pathogens,
including their growth requirements, their
patterns of gene and protein expression,
and even their virulence. Axenic cultures
are particularly effective when applied to
acute infections by a single bacterial spe-
cies. In such cases, it can be relatively
straightforward to pinpoint the pathogen
in question and to identify antibiotics
that should be able to eradicate, or at
least suppress, the infection.
However, there are reasons to question
the accuracy of axenic culture techniqueswhen they are applied to more complex
infections. For example, a single-isolate
culture may not faithfully reflect the
behavior of an organism when multiple
microbes are present in infected tissues,
or during chronic infections, when even
a single species may diversify as it adapts
to the varying selective pressures it might
encounter in those tissues. Pure cultures
of individual isolates from these infec-
tions may underestimate the diversity of
bacteria—both within and among spe-
cies—that contribute to a particular dis-
ease. Without an inclusive accounting of
these infecting microbes, it is difficult
to understand the pathogenesis of poly-
microbial or chronic infections and to
treat them. Specifically, a single bacterial
isolate could behave entirely differently6, October 8, 2014 ª2014 Elsevier Inc. 427
